Chen Q, Zhang M X, Guo L W, Zheng L Y, Liu C Y, Wang Y X, Liu Y, Wang H, Xu H F, Kang R H, Wang X Y, Liu S Z, Zhang S K
Department of Disease Prevention and Control, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Henan Engineering Research Center of Cancer Prevention and Control, Henan International Joint Laboratory of Cancer Prevention, Zhengzhou 450008, China.
Department of Disease Prevention and Control, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Henan Engineering Research Center of Cancer Prevention and Control, Henan International Joint Laboratory of Cancer Prevention, Zhengzhou 450008, China School of Public Health, Lanzhou University, Lanzhou 730000, China.
Zhonghua Zhong Liu Za Zhi. 2024 Oct 23;46(10):954-960. doi: 10.3760/cma.j.cn112152-20231024-00237.
To analyze the 5-year relative survival rate of cancer in Henan province based on cancer registration data. Cancer survival data were extracted from the cancer registration database of Henan province with the diagnosis date between January 1, 2010 and December 31, 2019 were included. The closing date of follow-up was set as December 31, 2019. The 5-year relative survival rate of cancer was calculated using the period survival analysis method and the Ederer II method in the R package "periodR", and the interest period was between 2015 and 2019. During the period of 2015-2019, the overall 5-year relative survival rate of cancer patients in Henan province was 43.6%, and after age-standardization, it was 40.2%. The overall 5-year relative survival rate showed the characteristics of higher survival rate in females than males (45.9% vs 34.7%, =39.60, <0.001) and higher survival rate in urban areas than rural areas (44.9% vs 39.1%, =12.97, <0.001). The 5-year relative survival rate for cancer patients among children aged 0-14 was 60.2%, and for adults aged 15 and above, it was 43.5%, which was standardized to 40.2% after age adjustment. There are two types of cancers with a standardized 5-year relative survival rate exceeding 70% (thyroid cancer at 82.2% and breast cancer at 71.6%), and four cancers with a rate below 30% (pancreatic cancer at 18.2%, liver cancer at 19.6%, lung cancer at 24.0%, and gallbladder cancer at 26.6%). The cancer 5-year survival rate in Henan Province is lower than that of the national average, indicating the need for continued enhancement of cancer prevention and control measures.
基于癌症登记数据分析河南省癌症患者的5年相对生存率。从河南省癌症登记数据库中提取诊断日期在2010年1月1日至2019年12月31日之间的癌症生存数据。随访截止日期设定为2019年12月31日。使用R包“periodR”中的期间生存分析方法和Ederer II方法计算癌症的5年相对生存率,观察期为2015年至2019年。2015 - 2019年期间,河南省癌症患者的总体5年相对生存率为43.6%,年龄标准化后为40.2%。总体5年相对生存率呈现女性生存率高于男性(45.9%对34.7%, =39.60, <0.001)以及城市地区生存率高于农村地区(44.9%对39.1%, =12.97, <0.001)的特征。0 - 14岁儿童癌症患者的5年相对生存率为60.2%,15岁及以上成年人的为43.5%,年龄调整后标准化为40.2%。有两种癌症的标准化5年相对生存率超过70%(甲状腺癌为82.2%,乳腺癌为71.6%),四种癌症的该比率低于30%(胰腺癌为18.2%,肝癌为19.6%,肺癌为24.0%,胆囊癌为26.6%)。河南省癌症5年生存率低于全国平均水平,表明需要持续加强癌症防控措施。